Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Study of Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone (CHOP) With Ofatumumab in Patients With Richter's Syndrome (CHOP-OR)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2015 by University of Oxford.
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborators:
GlaxoSmithKline
Cancer Research UK
Oxford University Hospitals NHS Trust
NCRI CLL Subgroup
Information provided by (Responsible Party):
University of Oxford
ClinicalTrials.gov Identifier:
NCT01171378
First received: July 22, 2010
Last updated: May 27, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2016
  Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):